ArticleCureus2024
Evaluation of Clinical Outcomes and Recurrence After Surgical Excision of Oral Leukoplakia: A Prospective Cohort Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Toluidine Blue and Chlorin-e6 Mediated Photodynamic Therapy in the Treatment of Oral Potentially Malignant Disorders: A Systematic Review.International journal of molecular sciences · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the clinical outcomes and recurrence patterns in cases of surgical excision of oral leukoplakia and identify key factors associated with disease recurrence and malignant transformation. MATERIALS AND
methodsThirty patients aged 18-70 years who were diagnosed with oral leukoplakia through clinical and histopathological evaluation, with lesions larger than 1 cm
resultsOverall, 27% of patients experienced recurrence, with higher recurrence rates in nonhomogenous lesions (40%), tobacco users (35%), and dysplastic lesions (100%). Factors such as a history of tobacco use and histopathological dysplasia were strongly associated with an increased risk of recurrence.
conclusionThis study highlighted the significance of lesion type, dysplasia, and patient risk factors such as tobacco use in predicting postsurgical recurrence. Close follow-up and risk factor modification are recommended to optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.